Annual Accounts Payable
$355.00 K
+$233.00 K+190.98%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual accounts payable is $355.00 thousand, with the most recent change of +$233.00 thousand (+190.98%) on December 31, 2023.
- During the last 3 years, GYRE annual accounts payable has risen by +$104.00 thousand (+41.43%).
- GYRE annual accounts payable is now at all-time high.
Performance
GYRE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$303.00 K
+$32.00 K+11.81%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly accounts payable is $303.00 thousand, with the most recent change of +$32.00 thousand (+11.81%) on September 30, 2024.
- Over the past year, GYRE quarterly accounts payable has dropped by -$52.00 thousand (-14.65%).
- GYRE quarterly accounts payable is now -14.65% below its all-time high of $355.00 thousand, reached on December 31, 2023.
Performance
GYRE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
GYRE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +191.0% | -14.7% |
| 3 y3 years | +41.4% | +8.6% |
| 5 y5 years | +41.4% | +8.6% |
GYRE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +191.0% | -14.7% | +11.8% |
| 5 y | 5-year | at high | +191.0% | -14.7% | +11.8% |
| alltime | all time | at high | +191.0% | -14.7% | +11.8% |
Gyre Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $303.00 K(+11.8%) |
| Jun 2024 | - | $271.00 K(-17.9%) |
| Mar 2024 | - | $330.00 K(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $355.00 K(+191.0%) | $355.00 K(+27.2%) |
| Mar 2023 | - | $279.10 K |
| Dec 2022 | $122.00 K(-51.4%) | - |
| Dec 2021 | $251.00 K | - |
FAQ
- What is Gyre Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Gyre Therapeutics?
- What is Gyre Therapeutics annual accounts payable year-on-year change?
- What is Gyre Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly accounts payable year-on-year change?
What is Gyre Therapeutics annual accounts payable?
The current annual accounts payable of GYRE is $355.00 K
What is the all time high annual accounts payable for Gyre Therapeutics?
Gyre Therapeutics all-time high annual accounts payable is $355.00 K
What is Gyre Therapeutics annual accounts payable year-on-year change?
Over the past year, GYRE annual accounts payable has changed by +$233.00 K (+190.98%)
What is Gyre Therapeutics quarterly accounts payable?
The current quarterly accounts payable of GYRE is $303.00 K
What is the all time high quarterly accounts payable for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly accounts payable is $355.00 K
What is Gyre Therapeutics quarterly accounts payable year-on-year change?
Over the past year, GYRE quarterly accounts payable has changed by -$52.00 K (-14.65%)